What is the Role of Protein Degradation in Drug Resistance?
Protein degradation pathways can contribute to drug resistance in cancer. Cancer cells may upregulate the expression of proteins that degrade therapeutic agents or their targets, diminishing drug efficacy. Moreover, alterations in these pathways can affect the stability and activity of proteins involved in cell survival and apoptosis, enabling cancer cells to evade the cytotoxic effects of treatments.
